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Abstract
Background: Chicken Mx belongs to the Mx family of interferon-induced dynamin-like GTPases, which in some species
possess potent antiviral properties. Conflicting data exist for the antiviral capability of chicken Mx. Reports of anti-influenza
activity of alleles encoding an Asn631 polymorphism have not been supported by subsequent studies. The normal
cytoplasmic localisation of chicken Mx may influence its antiviral capacity. Here we report further studies to determine the
antiviral potential of chicken Mx against Newcastle disease virus (NDV), an economically important cytoplasmic RNA virus of
chickens, and Thogoto virus, an orthomyxovirus known to be exquisitely sensitive to the cytoplasmic MxA protein from
humans. We also report the consequences of re-locating chicken Mx to the nucleus.
Methodology/Principal Findings: Chicken Mx was tested in virus infection assays using NDV. Neither the Asn631 nor
Ser631 Mx alleles (when transfected into 293T cells) showed inhibition of virus-directed gene expression when the cells
were subsequently infected with NDV. Human MxA however did show significant inhibition of NDV-directed gene
expression. Chicken Mx failed to inhibit a Thogoto virus (THOV) minireplicon system in which the cytoplasmic human MxA
protein showed potent and specific inhibition. Relocalisation of chicken Mx to the nucleus was achieved by inserting the
Simian Virus 40 large T antigen nuclear localisation sequence (SV40 NLS) at the N-terminus of chicken Mx. Nuclear re-
localised chicken Mx did not inhibit influenza (A/PR/8/34) gene expression during virus infection in cell culture or influenza
polymerase activity in A/PR/8/34 or A/Turkey/50-92/91 minireplicon systems.
Conclusions/Significance: The chicken Mx protein (Asn631) lacks inhibitory effects against THOV and NDV, and is unable to
suppress influenza replication when artificially re-localised to the cell nucleus. Thus, the natural cytoplasmic localisation of
the chicken Mx protein does not account for its lack of antiviral activity.
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Introduction
Mx proteins are interferon (IFN)-induced dynamin-like GTPases
found in all vertebrate species examined so far. The murine Mx1
protein was the first Mx protein to be discovered, when mice of the
inbred A2G strain were found to resist doses of influenza A virus
that were lethal to other mouse strains [1,2]. Numerous studies have
since confirmed the critical importance of Mx1 for influenza
resistance in mice, independent from other IFN-induced genes
[3,4,5,6]. Mx proteins have been identified in diverse host species
and exhibit a range of antiviral activities. While the murine Mx1
protein has specific activity against orthomyxoviruses, the human
MxA protein inhibits a broad spectrum of viruses (including
members of the Orthomyxoviridae, Paramyxoviridae, Rhabdoviridae,
Bunyaviridae, Hepadnaviridae and Asfaviridae) [7]. Murine Mx1 and
human MxA mediate their anti-influenza effects via distinct
mechanisms: Mx1 is nuclear and inhibits primary transcription of
thevirusgenome[8],whilethecytoplasmichumanMxAprotein[9]
affects an ill-defined post-transcriptional step [10] probably via an
interaction with the nucleoprotein [11]. In the case of the related
orthomyxovirus, THOV, human MxA has a particularly profound
antiviral effect. Indeed, levels of MxA which are not sufficient to
affect influenza growth are still inhibitory to THOV [12], and MxA
is capable of reducing THOV titres by 1,000,000-fold in cell culture
[12], while in similar experiments MxA reduced influenza titres by
200-fold [13]. In contrast, certain other Mx proteins lack
demonstrable antiviral activities, such as duck Mx [14], the rat
Mx3 protein [15] and the human MxB protein [13].
The chicken Mx protein was first cloned from a White Leghorn
strain of chicken in 1995, and found to be devoid of detectable
antiviral activity [16]. Subsequently, Ko et al. reported that the
chicken Mx gene was highly polymorphic, and that the Mx alleles
of some breeds of chicken did have activity against influenza virus
and vesicular stomatitis virus (VSV) [17]. These authors showed
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crucial determinant of anti-VSV activity (Asn631 is active and
Ser631 is inactive against VSV) [18]. Although this finding
sparked considerable interest in the prospect of selectively
breeding chickens bearing Asn631 alleles for enhanced influenza
resistance, subsequent investigations revealed that the Asn631
polymorphism did not confer influenza resistance in cell culture
[19] or in chicken challenge studies [20]. Since the activity of the
endogenous chicken Mx proteins might potentially be confounded
by inadequate IFN-induced expression or the effect of other
polymorphisms, we derived the Mx allele of the Japanese Shamo
(SHK) breed of chicken by site-specific mutagenesis, since this was
the only allele previously reported to inhibit influenza virus [17].
However, contrary to the previous report, our data showed that
expression of the SHK chicken Mx protein did not inhibit
influenza virus replication or gene expression [19].
The aim of this study was to evaluate whether the antiviral
capacity of the chicken Mx protein was influenced by its
cytoplasmic location. We therefore tested it against NDV, an
economically important cytoplasmic RNA virus of chickens, and
Thogoto virus, an orthomyxovirus known to be exquisitely
sensitive to cytoplasmic Mx proteins. We also report the
consequences of re-locating chicken Mx to the nucleus. Our
analysis focused on the allele from the Shamo (SHK) chicken line
(Asn631) which reportedly inhibited VSV and was previously
regarded as the prototype functional chicken Mx allele [17]. In
parallel, a Ser631 chicken Mx allele (8.1) was assessed (presumed
non-functional since the Ser631 polymorphism destroys antiviral
activity against VSV [18]), together with the known antiviral Mx
proteins murine Mx1 and human MxA.
Results
Activity of Chicken Mx against Newcastle Disease Virus
NDV was chosen as a candidate to test for sensitivity to the
chicken Mx protein because (i) NDV is an RNA virus belonging to
the Paramyxoviridae family, several members of which are sensitive
to the human MxA protein [21,22,23,24,25,26]; (ii) NDV
replicates exclusively in the cytoplasm of the host cell, where the
chicken Mx protein is located and (iii) NDV is an important avian
pathogen which poses a serious economic threat to the poultry
industry.
To determine whether NDV was sensitive to inhibition by the
chicken Mx protein, NDV-directed gene expression was measured
using flow cytometry in 293T cells that were transiently transfected
with Mx expression plasmids. The use of a recombinant GFP-
expressing NDV strain (NDV-GFP) (described by Engel-Herbert
et al. (2003) [27]) allowed the direct detection of virus-contingent
gene expression by GFP autofluorescence. GFP autofluorescence
in infected cells was previously shown to be as sensitive as viral
antigen detection by immunofluorescence [27].
293T cells were co-transfected with an Mx expression construct
and a plasmid expressing the DsRed-express fluorescent protein
(Clontech) at a ratio of 3:1. 48 h post-transfection, cells were
infected with NDV-GFP. 15 h later the cells were analysed by flow
cytometry. DsRed fluorescence was used to differentiate between
the transfected and untransfected sub-populations and GFP
fluorescence was used as a marker of productive infection by
NDV. Fig. 1 shows representative frequency distributions of the
GFP fluorescence in cells transfected with the indicated constructs
(Panel A), and the mean % GFP positive cells from independent
experiments (n=6) (Panel B). To derive the data shown in Panel
B, a fluorescence threshold marker (M1) was placed, as shown, to
demarcate the infected GFP positive cells.
The background fluorescence detected in uninfected, pcDNA3-
transfected cells is shown in sub-panel a (Fig. 1A). When pcDNA3
transfected cells were infected with NDV-GFP, two peaks were
seen corresponding to uninfected and infected sub-populations of
cells (Fig. 1A sub-panel b). In cells transfected with human MxA,
there was a significantly lower proportion of GFP positive cells
(67% relative to the pcDNA3 control) (p,0.01) (Fig. 1A sub-panel
c and Fig. 1B). The mutant MxA protein, T103A, did not produce
this reduction in the NDV-GFP signal (Fig. 1A sub-panel d and
Fig. 1B). Both the SHK and 8.1 chicken Mx alleles also failed to
inhibit NDV-GFP expression, and the proportion of GFP positive
cells was actually slightly increased relative to pcDNA3-transfected
cells (Fig. 1A sub-panels g and h and Fig. 1B). Similarly, cells
transfected with murine Mx1 (or its K49A mutant) had a slightly
higher proportion of GFP positive cells than cells transfected with
pcDNA3 (Fig. 1A sub-panels e and f, and Fig. 1B).
Activity of chicken Mx against Thogoto virus
The observation that NDV was sensitive to inhibition by human
MxA but unaffected by murine Mx1 is consistent with the sub-
cellular distribution of these two proteins and the cytoplasmic
location of NDV replication. Chicken Mx also resides in the
cytoplasm [16] but did not apparently inhibit NDV. However, the
level of inhibition observed for human MxA was fairly modest, so
we considered that the NDV assay was not a sufficiently rigorous
test. In contrast, THOV is highly sensitive to human MxA [12],
and we therefore tested whether THOV was sensitive to chicken
Mx using a THOV minireplicon system. In minireplicon systems,
a virus-like reporter RNA and the viral polymerase/NP replication
complex proteins (3P/NP) are co-expressed from transfected
plasmids. Transcriptionally active viral ribonucleoprotein com-
plexes (vRNPs) are reconstituted intracellularly and the reporter
RNA is transcribed and replicated, culminating in the expression
of the reporter gene. Orthomyxovirus minireplicon systems have
been widely used for the sensitive detection of the antiviral activity
of co-expressed Mx proteins [11,19,28,29].
Plasmids expressing THOV 3P/NP and a plasmid expressing a
THOV-like negative sense luciferase RNA under the control of
the human PolI promoter were transfected into 293T cells
together with either Mx expression plasmids or empty vector
(Fig. 2). Omission of the NP showed, as expected, that reporter
activity was dependent on THOV vRNP reconstitution. Trans-
fection of the human MxA expression plasmid caused a marked
(,90%) inhibition of luciferase activity in the THOV system,
whereas a GTPase defective mutant MxA T103A was not
inhibitory, thus demonstrating the sensitivity of this assay for
detecting inhibition specific to a functional human MxA protein
(Fig. 2). Transfection of the SHK chicken Mx expression plasmid
did not alter luciferase activity compared to the pcDNA3 control.
The 8.1 (Ser631) chicken Mx allele did produce a slight reduction
(p,0.05) in reporter activity (relative to pcDNA3), although there
was not a significant difference between the values obtained for the
SHK and 8.1 alleles.
Artificial nuclear re-localisation of chicken Mx proteins
Earlier work in our laboratory showed that chicken Mx failed to
inhibit influenza gene expression or influenza minireplicon systems
[19]. Other studies on the human MxA and rat Mx2 proteins
showed that translocation of these proteins from their natural
cytoplasmic location to the nucleus enhanced or revealed,
respectively, anti-influenza activities [30,31]. It was therefore
hypothesised that artificial re-localisation of the chicken Mx
protein from its usual cytoplasmic location to the cell nucleus, the
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antiviral activity on it.
In order to re-direct chicken Mx to the cell nucleus, the SV40
large T antigen nuclear localization signal (NLS) was introduced at
the N-termini of the chicken Mx coding sequence of the SHK and
8.1 alleles (this being the same strategy used by previous
investigators to re-localise human MxA [31]). Immunofluorescent
staining of transfected 293T cells using a monoclonal antibody
that cross-reacts with avian, human and mouse Mx proteins
confirmed that the wild type SHK Mx protein was restricted to the
cytoplasm whereas the NLS-tagged proteins were redirected to
large, discrete structures of unknown identity within the cell
nucleus (Fig. 3A). These structures were morphologically distinct
from the small punctate bodies characteristic of murine Mx1
localisation (Fig. 3A and [32]). To check expression levels of the
nuclear-localised chicken Mx constructs, Western blotting was
performed with the anti-Mx monoclonal antibody. Murine Mx1
and chicken Mx proteins were detected consistent with their
expected sizes (72 and 75 kDa respectively [16,33]) (Fig. 3B lanes 1
and 2). Densitometry revealed that there was less than a 2-fold
difference in the steady-state level of nuclear-localised SHK Mx
(lane 3) relative to wild type SHK Mx (lane 2) and murine Mx1
(lane 1).
Nuclear-localised chicken Mx does not inhibit influenza
replication
The activity of the nuclear-localised chicken Mx was assessed
using influenza minireplicon assays. In an A/PR/8/34 mini-
replicon system in 293T cells (Fig. 4A), co-transfection of murine
Mx1 or human MxA resulted in significant reduction in luciferase
reporter activity, while co-transfection of chicken Mx (SHK or 8.1)
had no effect as anticipated from previous studies [19]. Both of the
nuclear-localised chicken Mx alleles (SHK NLS and 8.1 NLS)
paradoxically caused a small but reproducible increase in reporter
levels in this assay (Fig. 4A). SV40 ori competition for T-Ag in the
293T cells is not the cause, as care was taken to maintain a
constant ratio of origins in the various transfection cocktails. Next,
the Mx constructs were tested in a minireplicon system based on
the avian influenza strain A/Turkey/England/50-92/91 (H5N1)
in chicken DF-1 cells, thus supplying chicken host cell factors that
might be required for the function of chicken Mx. DF-1 cells are
IFN competent [34] and plasmid transfection induces IFN in
CEFs [35]. Therefore, the DF-1 cells were co-transfected with a
plasmid expressing the A/PR/8/34 NS1 gene, which was
previously shown to antagonise IFN induction in CEFs [35].
Omission of the NS1 plasmid from the transfection mix caused a
significant decrease in luciferase levels consistent with partial
suppression of the system by the induction of IFN (Fig. 4B). In this
assay, the murine Mx1 and human MxA proteins were inhibitory,
but the nuclear-localised chicken Mx proteins resembled their wild
type counterparts in showing no inhibitory effect (Fig. 4B).
Figure 1. Chicken Mx proteins do not inhibit NDV-directed
gene expression. 293T cells were co-transfected with a plasmid
expressing the DsRed-express fluorescent protein and either pcDNA3 or
a plasmid expressing the indicated Mx protein (human MxA, the MxA
mutant T013A, murine Mx1, the Mx1 mutant K49A, wild type SHK
(Asn631) or 8.1 (Ser631) chicken Mx). 48 h post-transfection, the cells
were infected with NDV-GFP at an MOI which achieved approximately
60% infection (as determined by flow cytometry). 15 h post-infection,
the cells were fixed and analysed by flow cytometry. Cells were then
gated according to their expression of DsRed, and analysed for GFP
fluorescence in the FL1-H channel. Panel A shows representative
histograms for the GFP fluorescence in DsRed positive cells that were
co-transfected with the indicated plasmids. Sub-panel (a) shows the
background GFP fluorescence in uninfected, pcDNA3-transfected cells.
The fluorescence threshold marker (M1) demarcates between GFP
negative and positive cells. Panel B shows data derived from 6
replicates and bar heights show the % GFP positive cells expressed
relative to that for the pcDNA3 control. The mean (and SD) are shown
for DsRed positive cells co-transfected with the constructs as indicated.
* indicates a significant difference (Students t-test) relative to pcDNA3
(p,0.05).
doi:10.1371/journal.pone.0012151.g001
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gene expression in the equivalent THOV minireplicon assay
(Fig. 2).
Finally, the nuclear-targeted chicken Mx proteins were tested
for their ability to inhibit influenza A/PR/8/34 gene expression,
using the flow cytometry-based assay which was previously
described [19]. Briefly, 293T cells were co-transfected with Mx
expression plasmids and a plasmid expressing GFP in a ratio of
3:1, and 48 h later infected with A/PR/8/34 at a multiplicity that
achieved approximately 60% infection, as determined by FACS
analysis using anti-influenza RNP-specific antibody, and phyco-
erythrin (PE)-conjugated secondary antibody. To identify the
positively transfected sub-population, cells were gated for their
GFP fluorescence and then analysed for PE staining in the FL-2
channel. As expected, transfection of either murine Mx1 or human
MxA reduced the proportion of antigen positive cells compared to
transfection with pcDNA3 (Fig. 4C). However, transfected 293T
cells expressing SHK NLS or 8.1 NLS sustained equivalent levels
of influenza (A/PR/8/34) gene expression compared to cells
transfected with the empty vector pcDNA3 or with the wild type
chicken Mx proteins (Fig. 4C).
Discussion
There are several lines of evidence which indicate that sub-
cellular localisation is key determinant of the antiviral activity of Mx
proteins. Firstly, murine Mx1, which localises to the nucleus, is
ineffective against cytoplasmic viruses whereas the cytoplasmic
human MxA protein has a much broader spectrum of susceptible
viruses including those that replicate in the cytoplasm. Secondly,
artificial re-localisation of the human MxA protein to the nucleus
was shown to enhance its ability to inhibit influenza virus [31] and
influenza minireplicon systems [11]. Interestingly, nuclear-localised
MxA acts like murine Mx1 and suppresses primary transcription
[31]. Thirdly, the rat Mx2 protein has no anti-influenza activity
when in its natural cytoplasmic location, but gains this ability upon
translocation to the nucleus [30]. It was therefore reasonable to
ascertainwhether thesub-cellular distributionof chicken Mx was an
important determinant in its antiviral activity (or lack thereof), and
whether an otherwise inactive protein might gain antiviral activity
upon nuclear re-localisation.
The avian paramyxovirus, NDV, was chosen as a representative
cytoplasmic RNA virus relevant to chickens. Although we were
Figure 2. Chicken Mx proteins lack activity in a THOV minireplicon system. 293T cells were transfected with THOV PB1, PB2, PA and NP, a
plasmid encoding a luciferase THOV minireplicon and a SEAP expressing plasmid, together with pcDNA3 or a plasmid expressing the indicated Mx
protein (human MxA, the MxA T103A mutant, wild type chicken Mx proteins SHK (Asn631) and 8.1 (Ser631) and their nuclear-localised counterparts
SHK NLS and 8.1 NLS). 48 h post-transfection, luciferase activity was measured and is shown as relative light units (rlu). The mean (and SD) of 3
replicates is shown. * indicates significant difference (Students t-test) relative to pcDNA3 (p,0.05).
doi:10.1371/journal.pone.0012151.g002
Figure 3. Nuclear re-localisation of chicken Mx. 293T cells were transfected with pcDNA3 or plasmids expressing murine Mx1, SHK chicken Mx,
or chicken Mx constructs containing the SV40 NLS at their N-termini (SHK NLS and 8.1 NLS). Panel A: 48 h post transfection, cells were stained using a
species cross-reactive Mx specific monoclonal antibody (M143) followed by a FITC-conjugated anti-mouse antibody. Nuclei were counterstained with
DAPI. Merged images are shown composed of overlaid images from the FITC and DAPI channels. Scale bar measures 10 um. Panel B: 48 h post
transfection, cell lysates were prepared and 3 ug of total protein were loaded per sample for SDS-PAGE (7.5% resolving, 4% stacking). Western
blotting was performed the anti-Mx antibody M143, followed by an anti-mouse alkaline phosphatase-conjugated antibody and detection using ECL.
Lane 1: murine Mx1; Lane 2: SHK chicken Mx; Lane 3: SHK NLS. The position of the 79 kDa size marker is indicated by the arrow.
doi:10.1371/journal.pone.0012151.g003
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inhibition by wild type MxA, we were unable to detect any
significant inhibition by chicken Mx (Fig. 1). The inability of
murine Mx1 to inhibit NDV gene expression was expected since
murine Mx1 is nuclear while all steps of the NDV life cycle occur
in the cytoplasm. These data do not rule out an effect of chicken
Mx on downstream events such as NDV packaging and egress,
although there is no known precedent for Mx proteins targeting
these events. The apparent small enhancement of NDV-GFP
expression in cells transfected with either chicken Mx, murine
Mx1 or the mutant K49A protein is of unknown biological
relevance.
The THOV minireplicon system was highly sensitive to the
human MxA protein, consistent with previous in vitro and in vivo
reports which demonstrate that human MxA is particularly
effective in restricting THOV [12,36]. However, the prototype
functional SHK chicken Mx allele (Asn631) did not have any
inhibitory effect against the THOV minireplicon (Fig. 2). The
minor but reproducible reduction in reporter levels associated with
8.1 chicken Mx (Ser631) may be indicative of some weak antiviral
activity of this allele, but we are not convinced it is biologically
significant, in view of the much greater reduction achieved by
human MxA and the lack of a statistical difference between the
values for the SHK and 8.1 alleles. These data demonstrate that
the Asn 631 allele of chicken Mx does not inhibit the
transcription/replication activity of the THOV polymerase.
The addition of the SV40 NLS at the N-terminus of the chicken
Mx ORF successfully directed the protein to the nucleus (Fig. 3).
However, nuclear-localised chicken Mx was still unable to inhibit
influenza gene expression (Fig. 4C), influenza minireplicon systems
conducted in both 293T and chicken DF-1 cells (Figs. 4A and 2B)
or the THOV minireplicon (Fig. 2). The nuclear localised chicken
Mx proteins unavoidably have additional N-terminal amino acids
comprising the FLAG-tagged NLS epitope. N-termini of Mx
proteins show considerable variability [16] and tolerate N-terminal
alterations. We find that N-terminal FLAG tagged murine Mx1
retains its activity (data not shown), and others have reported
similarly for N-terminal FLAG tagged MxA [37]. Therefore, while
we cannot formally exclude the possibility, it is unlikely that the
Figure 4. Nuclear localized chicken Mx lacks anti-influenza
activity. Panel A: Effect on influenza A/PR/8/34 minireplicon system.
293T cells were co-transfected with plasmids expressing the PB1, PB2,
PA and NP proteins of influenza A/PR/8/34, a plasmid encoding a
luciferase minireplicon, and a SEAP-expressing plasmid, together with
either pcDNA3 or a plasmid expressing the indicated Mx protein
(murine Mx1, human MxA, wild type chicken Mx proteins SHK (Asn631)
and 8.1 (Ser631) and their nuclear-localised counterparts SHK NLS and
8.1 NLS). 48 h post-transfection, luciferase activity was measured and is
shown as SEAP-corrected relative light units (rlu). The mean (and SD) of
3 replicates is shown. * indicates p,0.05 (Students t-test) relative
to pcDNA3. Panel B: Effect on influenza A/Turkey/England/50-92/91
minireplicon system. DF-1 cells were transfected with plasmids
encoding A/Turkey/England/50-92/91 PB1, PB2, PA and NP, A/PR/8/34
NS1, an influenza minireplicon plasmid encoding luciferase, and a SEAP
expressing plasmid together with pcDNA3 or a plasmid expressing the
indicated Mx protein (murine Mx1, human MxA, wild type chicken Mx
proteins SHK (Asn631) and 8.1 (Ser631) and their nuclear-localised
counterparts SHK NLS and 8.1 NLS). 48 h post-transfection, luciferase
activity was measured and is shown as relative light units (rlu). The
mean (and SD) of 6 replicates is shown. * indicates p,0.05 (Students t-
test) relative to pcDNA3. Panel C: Effect on influenza A/PR/8/34 gene
expression. 293T cells were co-transfected with Mx-expressing plasmids
(or pcDNA3) and pEGFP-C1 and infected after 48 h with influenza A/PR/
8/34. 15 h post-infection, the cells were stained for influenza vRNP and
analysed by flow cytometry. The percentage of antigen positive cells is
expressed relative to that of the pcDNA3 control. The mean (and range)
of 2 replicates is shown for GFP positive cells co-transfected with the
indicated constructs.
doi:10.1371/journal.pone.0012151.g004
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inability of nuclear localised chicken Mx to inhibit influenza.
However, it should be noted that 15 out of a total of 18 positively
selected codons are located in the N-terminal region of avian Mx
proteins, suggesting some evolutionary significance for this region
[38]. We therefore concluded that, subject to the above caveat,
retargeting chicken Mx to the nucleus does not confer on it
inhibitory properties against influenza virus.
Thus, in the range of antiviral assays described herein, chicken
Mx lacks any antiviral capabilities, despite the presence of the
Asn631 polymorphism. These data support other reports [19,20]
in demonstrating that the Asn631 polymorphism is not a decisive
determinant of the antiviral activity of chicken Mx despite an
earlier report to the contrary [18]. Recent evolutionary analyses
show, using inter-specific comparisons of Mx sequences, that the
codon at position 631 of the chicken Mx protein is not positively
selected [38]. This also suggests that the Asn631 polymorphism is
not associated with in vivo resistance to significant chicken
pathogens (unless it is also associated with a deleterious phenotypic
trait).
However, in view of the high level of polymorphism in the
chicken Mx gene, it remains possible that alleles other than
those tested here might have antiviral activity. Hence, the
orthomyxovirus minireplicon assays and the flow cytometry-
based assays used here could be used as efficient screens for
antiviral alleles, which might then be harnessed to increase viral
resistance via selective breeding. Other relevant viruses could
also be tested (and in the case of VSV, retested) for their
sensitivity to the Asn631 chicken Mx allele. In particular,
infectious bursal disease virus, a chicken pathogen reported to
be sensitive to human MxA [39], could be tested against chicken
Mx in the future. However, it is interesting that the antivirally
inactive human MxB protein affects nucleocytoplasmic traffick-
ing and cell cycle progression [40], and that human MxA has
effects upon cellular processes such as intracellular calcium
signalling [41], cell motility [42], apoptosis [43], and endocy-
tosis [44]. Therefore, despite the absence of an antiviral
phenotype, it is clearly premature to consider chicken Mx as a
functionless/vestigial protein, and timely to address its potential
cellular effects.
Materials and Methods
Cells, viruses & plasmids
293T cells and DF-1 cells were obtained from the ATCC Cell
Biology Collection and were grown according to ATCC
guidelines. Influenza infections were performed with egg-grown
A/PR/8/34 (Cambridge) (2610
8 PFU/ml) which was kindly
provided by Dr Paul Digard (University of Cambridge). NDV-
GFP is a recombinant lentogenic NDV strain (Clone-30) which
contains the GFP gene inserted into the intergenic region
between the fusion and hemagglutinin-neuraminidase proteins.
This was previously characterised and kindly provided by Dr
Angela Ro ¨mer-Oberdo ¨rfer (Friedrich-Loeffler-Institutes, Insel
Riems, Germany) [27]. Plasmids pcDNA-PB1, -PB2, –PA, –NP
and –NS1 [45,46], expressing the indicated proteins of A/PR/8/
34 (H1N1) were kindly provided by Dr. Paul Digard. Plasmids
PolI/II 50-92-PB1, -PB2, -PA and –NP express proteins from A/
Turkey/England/50-92/91 (H5N1) and were generously provid-
ed by Prof. Wendy Barclay (Imperial College London) [47]. The
construction of plasmids expressing an influenza virus-based
luciferase minireplicon RNA under the control of either the
human RNA polymerase I promoter or the chicken RNA
polymerase I promoter was described previously [19]. Expression
constructs for wild type and mutant murine Mx1 and human
MxA proteins (pcDNA3-mMx1(wt), pcDNA3-mMx1(K49A),
pcDNA3-HA-MxA(wt) and pcDNA3-HA-MxA(T103A)) were
kindly provided by Dr Georg Kochs [48,49]. MxA T103A [37]
and Mx1 K49A [50] have single amino acid substitutions in their
GTP binding domains that abolish GTPase and antiviral activity.
The plasmids comprising the THOV minireplicon system were
also kindly supplied by Dr Kochs. The pCAGGS expression
constructs for THOV PB1, PB2, PA and NP were generated by
insertion of the respective cDNAs from the T7-driven pBSK
expression vectors [51] into pCAGGS-MCS under the control of
the chicken b-actin promoter [52]. The luciferase-encoding
THOV minireplicon was generated by exchange of the NP open
reading frame of pHH21-vNP [51] for the firefly luciferase
cDNA, yielding pHH21-vNP-FF-Luc. The SHK chicken Mx
gene was derived by mutagenesis and the 8.1 chicken Mx gene
was cloned from a commercial chicken line as previously
described [19].
Construction of nuclear localised Mx proteins
To introduce the SV40 T-Ag NLS [53] at the N-terminus of the
chicken Mx sequences, a pair of annealed complementary
oligonucleotides with overhangs compatible with NheI and AgeI
were ligated into the parental plasmids (pchMxSHK and
pchMx8.1 [19]) digested with NheI and AgeI. The resulting
sequence encompassing these two sites (in bold) with codon triplets
indicated was: 59 GCTAGCGCTACAGGT ATG GAT TAC
AAA GAC GAT GAC GAC AAG CCT AAG AAG AAG AGG
AAG GTG GAA CCG GTA GAA CAG CAG AAC ATG 39,
which is predicted to encode the following peptide sequence with
the indicated features in parentheses: MDYKDDDDK (FLAG
tag) PKKKRKV (T-Ag NLS) EPVEQQN (vector derived stuffer)
M (first amino acid of Mx ORF). The Mx coding region and
flanking vector sequences for newly constructed plasmids were
confirmed by sequencing.
Plasmid transfection
Fugene 6 transfection reagent (Roche) was used to transfect DF-
1 and 293T cells using a ratio of 3 ml Fugene 6: 1 mg DNA. The
total mass of DNA transfected per well was 500 ng for a 24 well
plate and 2 mg for a 6 well plate. The manufacturer’s transfection
protocol was followed.
Immunofluorescence analysis of Mx expression
293T cells were seeded and transfected in glass chamber slides,
which had been coated with poly-D-lysine (Sigma P6407). 48 h
after transfection, cells were fixed for 10 min at room
temperature with 2% formaldehyde in PBS and then permeabi-
lised using 0.2% Triton X-100 with 10% goat serum in PBS. The
monoclonal antibody M143 [54] was then added at a dilution of
1:400 in PBS containing 0.1% Tween 20 and 10% goat serum.
After incubation for 1 h, the slides were washed three times in
PBS before incubation with a 1:100 dilution of FITC conjugated
anti mouse antibody (DakoCytomation F 0313) for 30 min in the
dark. After a further three washes in PBS, the slides were
mounted using Vectashield mountant and examined using a
Leica DMRXA microscope using 640 magnification. Images
were captured using a Photometrics Sensys camera and Leica
QFISH software (Leica Microsystems) in black and white through
DAPI and FITC filter sets. The FITC and DAPI images were
then given false colour before merging the images to give the final
result. Magnification and contrast settings were kept constant for
all images.
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Cells were transfected in 24 well plates with equal amounts of
plasmids expressing either murine Mx1, SHK Mx or SHK NLS.
Cells were lysed 48 h post-transfection in chilled RIPA buffer
(10 mM Tris pH 7.4, 1 mM EDTA, 150 mM NaCl, 1% w/v
sodium deoxycholate, 1% v/v Triton-X100, 0.1% w/v SDS,
0.25 mM PMSF). Samples (3 mg total protein per lane) were
subjected to discontinuous SDS-PAGE (7.5% resolving gel, 4%
stacking gel) and then transferred onto a PVDF membrane using
semi-dry blotting. The membrane was blocked in 1X blocking
buffer (Sigma B 6429) for 1 h, and then incubated for 90 min with
M143 (diluted 1: 500 in 1X blocking buffer). After washing, the
membrane was then incubated for 60 min with an alkaline
phosphatase-conjugated anti-mouse antibody (Sigma A-0162,
diluted 1: 1000 in 1X blocking buffer). The CDP-Star Universal
chemiluminescence detection kit (Sigma U-ALK) was then used in
accordance with the manufacturer’s instructions.
Luciferase minireplicon reporter assays
For orthomyxovirus minireplicon assays in 293T cells, each well
(24 well plate) received 25 ng of each of the plasmids expressing
the viral PB1, PB2, PA and NP proteins, 100 ng of a human PolI-
driven luciferase reporter plasmid, 50 ng of a plasmid expressing
secreted alkaline phosphatase (SEAP) [55], and 250 ng of an Mx
bearing plasmid or pcDNA3 control plasmid. For the A/Turkey/
50-92/91 system in DF-1 cells, cells were transfected with 125 ng
of a plasmid expressing the NS1 gene of A/PR/8/34, 25 ng of
each of the plasmids expressing the PB1, PB2, PA and NP
proteins, 100 ng of a chicken PolI-driven luciferase reporter
plasmid, 50 ng of a plasmid expressing SEAP and 125 ng of an
Mx bearing plasmid or pcDNA3 control plasmid. 48 h post-
transfection luciferase expression was assayed using the Bright-Glo
Luciferase Assay System (Promega) according to the manufactur-
er’s instructions. SEAP activity was determined using the
calorimetric assay described previously [55]. Where appropriate,
luciferase activity was normalised to the SEAP activity for each
well in order to account for minor differences in transfection
efficiencies.
Flow cytometric analysis of viral gene expression
293T cells were transfected with an Mx expressing plasmid (or
pcDNA3) (1.5 ug) and a plasmid expressing a fluorescent protein
(GFP or DsRed-express as appropriate) (0.5 ug). 48h post
transfection, cells were infected with either A/PR8/34 or NDV-
GFP. 15 h post-infection, the cells were trypsinised, washed in PBS
and then fixed for 10 min at room temperature using 2%
formaldehyde in PBS. For NDV-GFP infected cells, GFP
autofluorescence was determined directly in fixed cells. Influenza
(A/PR/8/34) gene expression was detected using indirect
immunofluorescence. The cells were first permeabilised for
10 min (using 0.2% Triton X-100 with 10% goat serum in
PBS), blocked for 15 min using 10% goat serum in PBS and then
incubated at room temperature for 1 h with a 1:200 dilution (in
0.02% Triton X-100 and 2% goat serum in PBS) of rabbit
polyclonal antisera to FPV (Rostock) vRNP [56], kindly provided
by Dr. Paul Digard (University of Cambridge). The cells were then
washed three times in PBA (PBS, 0.1% BSA, 0.01% sodium azide)
before incubation with a 1:20 dilution of anti-rabbit R-phycoer-
ythrin (PE) conjugated antibody (Sigma P-9537) on ice for 30 min
in the dark. Finally, the cells were washed a further three times in
PBA before detection of their fluorescence using a Becton
Dickinson FACSCalibur. For each sample, either 2610
4 or
1610
4 cells were analysed for their GFP or viral antigen
fluorescence (depending on the experiment). Cell Quest 3.3
software was used to analyse the data.
Statistical Analysis
Data were analysed for statistical significance using a two-tailed
Student’s t test assuming populations of unequal variance. The
number of independent data sets for each experiment is indicated
in the figure legends. Where appropriate, and unless otherwise
stated, data sets were compared to the pcDNA3 controls. The
threshold for significance was p,0.05.
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